Cargando…
Alterations in the glycome after HDAC inhibition impact oncogenic potential in epigenetically plastic SW13 cells
BACKGROUND: Defects in the type and degree of cellular glycosylation impact oncogenesis on multiple levels. Although the type of glycosylation is determined by protein sequence encoded by the genome, the extent and modifications of glycosylation depends on the activity of biosynthetic enzymes and re...
Autores principales: | Montgomery, McKale R., Hull, Elizabeth E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335691/ https://www.ncbi.nlm.nih.gov/pubmed/30651077 http://dx.doi.org/10.1186/s12885-018-5129-4 |
Ejemplares similares
-
Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition
por: Davis, McKale R., et al.
Publicado: (2016) -
HDAC inhibition induces EMT and alterations in cellular iron homeostasis to augment ferroptosis sensitivity in SW13 cells
por: Oliveira, Thais, et al.
Publicado: (2021) -
HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
por: Hull, Elizabeth E., et al.
Publicado: (2016) -
Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers
por: Hull, Elizabeth E., et al.
Publicado: (2017) -
Epigenetic Gene Regulation by Dietary Compounds in Cancer Prevention
por: Montgomery, McKale, et al.
Publicado: (2019)